|
|||||||||||||||||||||||||||||||||||
|
1 Review
|
Average Customer Review
Share your thoughts with other customers
Create your own review
|
|
Most Helpful First | Newest First
|
|
1 of 1 people found the following review helpful:
1.0 out of 5 stars
What you learn from this book is not worth the money,
By
This review is from: Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company (Hardcover)
This book is way overpriced for the information that it delivers. Besides being out-of-date, it focuses on what might be called discovery outsourcing with minimal information about preclinical development outsourcing. The author has littl to add, though he does explain preclinical research and the factors involved in its success rather lucidly. It's certainly not use the price they want for it. Find it used for less than $50 and it will be a reasonable purchase.
|
|
Most Helpful First | Newest First
|
|
Modern Strategy for Preclinical Pharmaceutical R&D: Towards the Virtual Research Company by David Cavalla (Hardcover - Sept. 1997)
$265.00
In Stock | |
 
| ||
